Skip to content

Five year outcome of minimally invasive surgical ablation of paroxysmal and persistent atrial fibrillation

Five year outcome of minimally invasive surgical ablation of paroxysmal and persistent atrial fibrillation - 5-year outcome Minimaze

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42532
Enrollment
66
Registered
2015-06-29
Start date
2015-07-28
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation fibrillation

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who have undergone minimal invasive surgical ablation for paroxysmal or persistent atrial fibrillation between 2008 and 2010 in the Academic Medical Center.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
-Freedom of any recurrence of atrial fibrillation, atrial flutter or atrial tachycardia, documented on ECG or 24-hour Holter within five years after the procedure without the use of antiarrhythmic drugs. -Sinus rhythm on electrocardiogram at follow up visit five years or more ofter the procedure. -Use of antiarrhythmic drugs at follow up visit.

Secondary

MeasureTime frame
-Functional status measured by the SF-36 Quality of Life questionnaire at 60 months follow up. -The occurrence of any procedure related complications and the occurrence of other clinical events during 60 months follow up. -Major adverse cardiac events (MACE) during 60 months or more follow up.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)